Technology

FDA Gambles on AI to Replace Lost Human Expertise
Technology FDA Gambles on AI to Replace Lost Human Expertise

The High-Stakes Transformation of America’s Health Regulator The sudden exodus of nearly a fifth of the professional workforce at the Food and Drug Administration has triggered an urgent and risky reliance on automated systems to maintain the integrity of the nation's medical supply chain. T

Bridging the Gap Between AI Innovation and Clinical Adoption
Technology Bridging the Gap Between AI Innovation and Clinical Adoption

Thousands of algorithms cleared by regulatory bodies are currently gathering digital dust on hospital servers because the leap from a laboratory success to a bedside victory remains the most difficult transition in modern medicine. While global analysts project that artificial intelligence could

How Can Machine Learning Future-Proof Evidence Generation?
Technology How Can Machine Learning Future-Proof Evidence Generation?

Faisal Zain has spent a career at the intersection of medical technology and pharmaceutical innovation, navigating the complex transition from manual data processing to automated, high-performance computing environments. As real-world evidence (RWE) evolves from a peripheral regulatory concept to a

Why Should Clinical Trials Move to Digital Recruitment?
Technology Why Should Clinical Trials Move to Digital Recruitment?

Suzanne Harris is a veteran patient advocate and the Senior Vice President of Marketing & Communications at SubjectWell, where she spearheads initiatives to modernize the intersection of clinical research and patient engagement. With a deep focus on patient-centric solutions, she has become a

Can Virtual GI Care Transform Outcomes and Reduce Costs?
Technology Can Virtual GI Care Transform Outcomes and Reduce Costs?

A New Frontier in Managing Gastrointestinal Health The staggering reality that nearly twenty percent of American adults currently grapple with chronic digestive issues has pushed the traditional healthcare infrastructure to a breaking point. With annual expenditures related to gastrointestinal

How Will Mark Cuban Redefine the Weight Loss Drug Market?
Technology How Will Mark Cuban Redefine the Weight Loss Drug Market?

The pharmaceutical industry is currently witnessing a gold rush of unprecedented proportions as the demand for GLP-1 medications outpaces the global supply chain and creates a wild west of pricing. While most corporate entities are sprinting to capitalize on the feverish hype surrounding drugs like

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later